Frailty in Daily Practice: Screening, Consultation and Education Activities

May 25, 2022 updated by: Jean Woo, Chinese University of Hong Kong

The present study is designed to to estimate the prevalence of frailty and pre-frailty and their associated factors in community-dwelling populations aged 50 years and above in Hong Kong, and to explore the views of participants taking part in a community health talks or activities on frailty about what the participants felt or had gained from participating, concerns, and suggestions for change or improvement.

A survey of 15000 people aged 50 years or older identified in community facilities will be conducted. The participants will be invited to their affiliated centres for a brief screening using the FRAIL scale and assessment. A series of community health talks or activities on frailty will be offered to the participants based on the frailty status.Questionnaire and screening tools will be administered by trained researchers.

Study Overview

Detailed Description

A 30-month community survey will be conducted, and the survey will be divided into three phases, namely study preparation and subject recruitment (6 months), data collection (18 months), and data entry and analysis (6 months).

A survey of 15000 people aged 50 years or older identified in community facilities (e.g., neighbourhood elderly centre, social centre for the elderly) will be conducted. The participants will be invited to their affiliated centres for a brief screening using the FRAIL scale and assessment. A series of community health talks or activities on frailty will be offered to the participants based on the frailty status. Questionnaire and screening tools will be administered by trained researchers.

The primary outcome will be the prevalence of frailty and pre-frailty. Secondary outcomes will cover physical performance measures including hand-grip strength and 5-chair stand test. Anthropometric and demographic data will also be collected using standardized methods and questionnaires respectively.

Views of participants taking part in a community health talks or activities on frailty about what the participants felt or had gained from participating, concerns, and suggestions for change or improvement will be explored by client satisfaction questionnaires.

Study Type

Observational

Enrollment (Actual)

5951

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, China
        • Chinese University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

People aged 50 years or older will be identified in community facilities (e.g., neighbourhood elderly centre, social centre for the elderly).

Description

Inclusion Criteria:

  • People aged 50 years or older
  • Chinese origin
  • Normally reside in Hong Kong
  • Could speak and understand Chinese
  • Willing to follow the study procedures

Exclusion Criteria:

-Live in a residential aged care facility

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty status
Time Frame: 1 day (Once only at screening)
Frailty status (i.e. robust, prefrail or frail) measured using the frailty scale (FRAIL) in which unabbreviated scale name is unavailable for this scale. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) and represent robust (0), pre-frail (1-2), and frail (3-5) health status.
1 day (Once only at screening)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Handgrip strength
Time Frame: 1 day (Once only at screening)
Handgrip strength measured using a dynamometer
1 day (Once only at screening)
5 chair stands
Time Frame: 1 day (Once only at screening)
Muscle endurance in the lower extremities - Participant will be required to rise from a chair a total of 5 times, as quickly as they could, with arms across their chest. The amount of time required to complete all 5 repetitions will be recorded.
1 day (Once only at screening)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: 1 day (Once only at screening)
Weight in kilogram measured using standardized method
1 day (Once only at screening)
Height
Time Frame: 1 day (Once only at screening)
Height in centimeter measured using standardized method
1 day (Once only at screening)
Waist circumference
Time Frame: 1 day (Once only at screening)
Waist circumference in centimeter measured using standardized method
1 day (Once only at screening)
Systolic blood pressure
Time Frame: 1 day (Once only at screening)
Systolic blood pressure in mmHg measured using standardized method
1 day (Once only at screening)
Diastolic blood pressure
Time Frame: 1 day (Once only at screening)
Diastolic blood pressure in mmHg measured using standardized method
1 day (Once only at screening)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean Woo, MD, Chinese University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2020

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

May 25, 2022

Study Registration Dates

First Submitted

October 23, 2019

First Submitted That Met QC Criteria

October 24, 2019

First Posted (Actual)

October 25, 2019

Study Record Updates

Last Update Posted (Actual)

May 26, 2022

Last Update Submitted That Met QC Criteria

May 25, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019.475

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on Health screening, community health talks or activities on frailty

3
Subscribe